Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 14,264 shares at $29.84 ($426K) on 2024-02-16, disclosed to the SEC on 2024-02-21.
Open-market sale of $426k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.84 | 7,132 | $213K | 50.0% |
| 2 | $29.84 | 7,132 | $213K | 50.0% |
| Total | $29.84 avg | 14,264 | $426K | 100% |
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |